Probably because of the anti-apoptotic and anti-inflammatory effects, G-CSF has also been used to treat nonhematopoietic targets including cerebral ischemia [44], spinal cord ischemia [45], infarct heart [46], and end stage liver disease [47]. This evidence concerns the gene CSF3 and End Stage Liver Disease.